Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of 693,452. The enterprise value is 202,852.
| Market Cap | 693,452 |
| Enterprise Value | 202,852 |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 1.78 million shares outstanding. The number of shares has increased by 57.78% in one year.
| Current Share Class | 1.78M |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | +57.78% |
| Shares Change (QoQ) | +42.46% |
| Owned by Insiders (%) | 6.37% |
| Owned by Institutions (%) | 8.55% |
| Float | 1.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | -0.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.04 |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.05 |
Financial Position
The company has a current ratio of 0.42
| Current Ratio | 0.42 |
| Quick Ratio | 0.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -272.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -119.32% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 154.72% |
| Revenue Per Employee | 97,154 |
| Profits Per Employee | -382,423 |
| Employee Count | 15 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 0.45 |
Taxes
| Income Tax | -97,279 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.29% in the last 52 weeks. The beta is 0.33, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -96.29% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 3.00 |
| Relative Strength Index (RSI) | 38.41 |
| Average Volume (20 Days) | 2,714 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, XAGE had revenue of 1.46 million and -5.74 million in losses. Loss per share was -4.96.
| Revenue | 1.46M |
| Gross Profit | 1.21M |
| Operating Income | -5.48M |
| Pretax Income | -5.83M |
| Net Income | -5.74M |
| EBITDA | -5.40M |
| EBIT | -5.48M |
| Loss Per Share | -4.96 |
Balance Sheet
The company has 1.11 million in cash and 618,632 in debt, giving a net cash position of 490,596 or 0.28 per share.
| Cash & Cash Equivalents | 1.11M |
| Total Debt | 618,632 |
| Net Cash | 490,596 |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | -3.98M |
| Book Value Per Share | -2.23 |
| Working Capital | -4.00M |
Cash Flow
In the last 12 months, operating cash flow was -4.29 million and capital expenditures -14,224, giving a free cash flow of -4.30 million.
| Operating Cash Flow | -4.29M |
| Capital Expenditures | -14,224 |
| Free Cash Flow | -4.30M |
| FCF Per Share | -2.42 |
Margins
| Gross Margin | 82.77% |
| Operating Margin | -376.05% |
| Pretax Margin | -400.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.78% |
| Shareholder Yield | -57.78% |
| Earnings Yield | -827.22% |
| FCF Yield | -620.79% |
Stock Splits
The last stock split was on May 14, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | May 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
XAGE has an Altman Z-Score of -37.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.28 |
| Piotroski F-Score | 3 |